Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Facciolongo

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 3, 2024
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infectionIlaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Scientific Reports|March 12, 2022
Inflammatory burden and persistent CT lung abnormalities in COVID-19 patientsGiulia Besutti, Paolo Giorgi Rossi, Marta Ottone, et al.
Clinical and Experimental Rheumatology|December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumoniaGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Pulmonary Therapy|May 17, 2026
Comparison of Three Devices Preventing Skin Damage During Facial Mask Ventilation in Acute Respiratory Failure: Multicenter Randomized Controlled Trial Protocol (3PROSNIVtrial)Raffaele Scala, Federica Andolfi, Giulia Ottaviano, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 3, 2024
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infectionIlaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Scientific Reports|March 12, 2022
Inflammatory burden and persistent CT lung abnormalities in COVID-19 patientsGiulia Besutti, Paolo Giorgi Rossi, Marta Ottone, et al.
Clinical and Experimental Rheumatology|December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumoniaGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Pulmonary Therapy|May 17, 2026
Comparison of Three Devices Preventing Skin Damage During Facial Mask Ventilation in Acute Respiratory Failure: Multicenter Randomized Controlled Trial Protocol (3PROSNIVtrial)Raffaele Scala, Federica Andolfi, Giulia Ottaviano, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 7